Blonder Tongue Laboratories Receivables

Blonder Tongue Laboratories (BDR) currently reports a receivables of $1.7M as of March 2025. That compares with $1.5M in the prior-year period — up 7.5% year over year. Use the charts on this page to explore Blonder Tongue Laboratories's receivables history and peer comparisons.

Blonder Tongue Laboratories's receivables increased from $1.5M to $1.7M — a 7.5% year-over-year increase (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Blonder Tongue Laboratories reported $1.7M in receivables as of March 2025. That compares with $1.5M in the prior-year period — up 7.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $1.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Blonder Tongue Laboratories, and consider following BDR for alerts when major investors trade the stock.

Blonder Tongue Laboratories is classified in the Technology sector. On receivables, it currently shows $1.7M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing BDR with unrelated industries.